Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2026 is 27.25% vs 7.86% in Jun 2025
Consolidate Net Profit
YoY Growth in quarter ended Jun 2026 is 58.31% vs 7.19% in Jun 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2026 is 42.91% vs 5.94% in Jun 2025
Interest
YoY Growth in quarter ended Jun 2026 is 0.00% vs -35.48% in Jun 2025
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Compare Quarterly Results Of Titan Biotech With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2026 is 21.18% vs -13.59% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 27.25% vs 7.86% in Jun 2025
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 61.37% vs -21.10% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 58.31% vs 7.19% in Jun 2025
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2026 is 28.63% vs -10.42% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 42.91% vs 5.94% in Jun 2025
Quarterly - Interest
QoQ Growth in quarter ended Jun 2026 is -16.67% vs -7.69% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 0.00% vs -35.48% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025






